Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested Capital

Nanobiotix (NBTX) Equity Ratio (2020 - 2025)

Nanobiotix has reported Equity Ratio over the past 6 years, most recently at 1.25 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 27.93% year-over-year to 1.25; the TTM value through Dec 2025 reached 1.25, down 27.93%, while the annual FY2025 figure was 1.25, 27.93% down from the prior year.
  • Equity Ratio for Q4 2025 was 1.25 at Nanobiotix, up from 1.53 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.33 in Q2 2021 and troughed at 1.53 in Q2 2025.
  • A 5-year average of 0.52 and a median of 0.35 in 2022 define the central range for Equity Ratio.
  • On a YoY basis, Equity Ratio climbed as much as 95.66% in 2023 and fell as far as 6088.45% in 2023.
  • Year by year, Equity Ratio stood at 0.26 in 2021, then tumbled by 271.89% to 0.45 in 2022, then skyrocketed by 95.66% to 0.02 in 2023, then crashed by 4865.26% to 0.97 in 2024, then fell by 27.93% to 1.25 in 2025.
  • Business Quant data shows Equity Ratio for NBTX at 1.25 in Q4 2025, 1.53 in Q2 2025, and 0.97 in Q4 2024.